Select Page

Why Mimosa?

The Mimosa tenuiflora tree is a symbol of ancient regenerative healing. In the 10th century, the Mayans were already utilizing its bark for its incredible capability to heal wounds. Today we have discovered that its roots also contains one of the highest levels of DMT from any botanical known to man. At MIMOSA, we aim to bring the healing power of entheogens such as the Mimosa tenuiflora tree back into service for greater good of humanity.

  

Origin Story

James Keim, Amanda Feilding, Bob Stanley, and other major figures in the psychedelic world shared a similar vision; they wanted to create an international company that would produce high-quality, natural entheogensDefinition: “becoming divine within” // chemical substance, typically of plant origin, that is ingested to produce a nonordinary state of consciousness for religious or spiritual purposes. at very affordable prices. Informed by ethical capitalism and grounded in morals and practices of the psychedelic community, Mimosa Therapeutics was formed as a Public Benefit Corporation.

Mission

To help people access the best, healthiest version of themselves through the careful and intentional use of entheogens.

Our Offerings Are

Safe
Uniform.
Consistent.
Sacred.
Inclusive.
Organic.

Our Commitments as a Public Benefit Corporation

A Team With Deep Roots

Leading Figures from the World of Psychedelics

Amanda Feilding

Co-founder, Director

The founder of the Beckley Foundation and one of the best-known and respected figures in the world of psychedelic research and drug policy.

James Keim

Co-founder, CEO

Previously served as CEO of OLP Therapeutics and other startups. He is also a psychedelic therapist, Fulbright Specialist, and co-author of the book, The Violence of Men.

Tyra Callaway

Vice President, Formulations

Brings significant experience from academic computational chemistry laboratories focused on drug design, protein function, and natural botanical preparations.

Bob Stanley

Chief Sacrament Officer
Senior Vice President

Bob Stanley is the Chief Garden Steward for Sacred Garden Community Church, was the co-founder of two previous life science informatics companies and was the founding chair of Decriminalize Nature, Oakland.

Antoni Gandia

Vice President for Bioreactor Production

He is the author of a book on mushrooms and of notable journal publications on mycelium. He has previously worked in the mycoprotien and mycoleather production industries.

Felix Blei

Vice President for Analytics

Is one of the world’s leading biochemists studying magic mushrooms and recently received the Paper of the Year award from Psychedelic Science Review.

John Turner

Senior Advisor

Before retiring, he served as a corporate attorney and business advisor in Silicon Valley for 17 years, most at Wilson Sonsini. John founded Trippingly.net, a leading source of reliable information on psychedelics.

James Fadiman

Chief Culture Officer

Author, researcher, and philosopher, he is one of the psychedelic world’s most popular figures and his books include The Psychedelic Explorer’s Guide.

Alan Rockefeller

Chief Mycologist

He is one of the world’s leading authorities on magic mushrooms with a special interest in understanding genetic variation among psilocybin varieties.

Jonathan Keim

Creative Director

After launching Indonesia’s first vegan gelato brand and two world-renowned life coach training schools, Jonathan Keim started working as a Brand Strategist and Creative Director for impact-based businesses.

Jake Houbiers

Brand Strategist

Jake founded Dutch design agency, Ministry of MEDIA working for NGO’s, whilst teaching at the University of Utrecht. His expertise is in hard to reach audiences and design strategies that inspire meaningful & postive change.

Investors

Integrated is a venture fund partnering with value-aligned companies and entrepreneurs that are transforming the health and well-being of our communities around the globe.

They are on a mission to redefine healthcare through the advancement of medicines and the integration of transformative therapies.

MIMOSA is a team of world renowned experts utilizing cutting edge science, technology, testing and production methods to make consistent, measurable, medical-grade natural entheogens available to the market at affordable prices.

Contact

Info@mimosatherapeutics.com